文献速递脑血管病外科

采用TOBAS标准评估未破裂低级别脑动静脉畸形的结局

Outcomes of Unruptured Low-Grade Brain Arteriovenous Malformations Using TOBAS (Treatment of Brain Arteriovenous Malformations Study) Criteria.
PubMed 文献 · World Neurosurg · 2022-09-08

本研究比较2006至2016年诊断的84例未破裂低级别脑动静脉畸形(Spetzler-Martin I-II级)患者接受介入或药物治疗的结局,主要终点为全因死亡和末次随访时改良Rankin量表(mRS)>2的致残性卒中。治疗组与未治疗组达到主要终点的比例无显著差异(12.7% vs 16.7%,P=0.744),5年Kaplan-Meier曲线概率亦无差异(P=0.07)。作者认为栓塞似乎并发症风险高,应谨慎使用。

要点

  • 治疗组与未治疗组主要终点无显著差异(12.7% vs 16.7%,P=0.744)。
  • 5年达到主要终点的概率两组无差异(P=0.07)。
  • 栓塞后并发症导致mRS>2占9.1%,其中80%发生在栓塞后。

核心结论

  • 本研究显示治疗与未治疗的未破裂低级别脑动静脉畸形之间无差异。
  • 栓塞似乎携带高并发症风险,应谨慎使用。
  • 病例数少必须鼓励谨慎解读,尤其因为自发性高破裂率。
  • 一个主要兴趣是当治疗标准有限时调查中心在病理学中的习惯。

研究设计与样本

  • 纳入2006年至2016年间诊断的未破裂低级别脑动静脉畸形成人患者。
  • 共84例患者,其中55例(65.5%)接受治疗,29例(34.5%)未治疗,临床和影像学特征无差异。
  • 治疗方式:栓塞25.5%,放射外科(单独30.9%;联合栓塞18.2%),手术(单独5.5%;联合栓塞20%)。
  • 主要终点为全因死亡和末次随访时改良Rankin量表(mRS)>2的致残性卒中。

主要发现

  • 未治疗组破裂率为6.7%/人年。
  • 治疗组12.7%(n=7)和未治疗组16.7%(n=5)达到主要评价标准(P=0.744)。
  • Kaplan-Meier曲线显示5年达到该标准的概率两组无差异(P=0.07)。
  • 并发症导致末次随访时mRS>2发生于9.1%的患者,其中80%的病例发生在栓塞后。

临床怎么用

  • 作者认为栓塞似乎携带高并发症风险,应谨慎使用。
  • 作者指出病例数少必须鼓励谨慎解读,尤其因为自发性高破裂率。

局限性

  • 病例数少必须鼓励谨慎解读,尤其因为自发性高破裂率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment of an unruptured brain arteriovenous malformation (bAVM) is a matter of debate, especially for low-grade bAVM (Spetzler-Martin grade I and II). The aim is to compare the outcomes of patients with low-grade unruptured bAVM after interventional or medical management in a pragmatic manner. METHODS: Adults with unruptured low-grade bAVM diagnosed between 2006 and 2016 were included. The primary end points were death from all causes and disabling stroke that resulted in a modified Rankin Scale (mRS) score >2 at last follow-up. RESULTS: Eighty-four patients presented with an unruptured Spetzler-Martin low-grade bAVM. Among these patients, 55 (65.5%) were treated and 29 (34.5%) were untreated, with no differences regarding clinical and radiologic characteristics. The modality of treatment was embolization in 25.5%, radiosurgery (alone, 30.9%; with embolization, 18.2%), and surgery (alone, 5.5%; with embolization, 20%). The rupture rate was 6.7% person-year in the untreated group; 12.7% (n = 7) of treated and 16.7% (n = 5) of untreated patients achieved the primary evaluation criteria (P = 0.744). Using a Kaplan-Meier curve, the probability of reaching this criterion at 5 years was not different between groups (P = 0.07). Complications resulting in an mRS score >2 at last follow-up occurred in 9.1%, in 80% of cases after embolization. CONCLUSIONS: This study shows no differences between treated and untreated low-grade bAVM. Embolization seems to carry a high risk of complication and should be used with caution. The small number of cases must encourage cautious interpretations especially because of the spontaneous high-rupture rate. One major interest is to investigate center habits in pathology when treatment standards are limited.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Dumot C, Picart T, Eker O, et al. Outcomes of Unruptured Low-Grade Brain Arteriovenous Malformations Using TOBAS (Treatment of Brain Arteriovenous Malformations Study) Criteria. World Neurosurg. 2022. PMID: 36089272. doi:10.1016/j.wneu.2022.08.152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。